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The worldwide prevalence of ADHD: 
is it an American condition?
RESEARCH REPORT
Attention-deficit/hyperactivity disorder (ADHD) is a behavioral disorder that affects up to 1 in 20 children in the USA. The predomi-
nance of American research into this disorder over the past 40 years has led to the impression that ADHD is largely an American dis-
order and is much less prevalent elsewhere. This impression was reinforced by the perception that ADHD may stem from social and cul-
tural factors that are most common in American society. However, another school of thought suggested that ADHD is a behavioral dis-
order common to children of many different races and societies worldwide, but that is not recognized by the medical community, per-
haps due to confusion regarding its diagnosis and/or misconceptions regarding its adverse impact on children, their families, and soci-
ety as a whole. In this article we present the available data, with a view to determining the worldwide prevalence of ADHD. A total of
50 studies were identified from a MEDLINE search for the terms ADHD, ADD, HKD, or attention-deficit/hyperactivity disorder and
prevalence combined, for the years 1982 to 2001. 20 were studies in US populations and 30 were in non-US populations. Analysis of these
studies suggests that the prevalence of ADHD is at least as high in many non-US children as in US children, with the highest prevalence
rates being seen when using DSM-IV diagnoses. Recognition that ADHD is not purely an American disorder and that the prevalence of
this behavioral disorder in many countries is in the same range as that in the USA will have important implications for the psychiatric
care of children.
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Attention-deficit/hyperactivity disorder (ADHD) is a
behavioral disorder believed to affect up to 1 in 20 chil-
dren in the USA (1). It is characterized by symptoms of
inattention and/or impulsivity and hyperactivity which
can significantly impact on many aspects of behavior and
performance, both at school and at home. In approxi-
mately 80% of children with ADHD, symptoms persist
into adolescence and may even continue into adulthood.
The effects of ADHD significantly impact on the individ-
ual throughout childhood and well into adult life, espe-
cially if not managed optimally; people with ADHD tend
to have a lower occupational status, poor social relation-
ships, and are more likely to commit motoring offences
and develop substance abuse (2). Parents and siblings also
suffer as a result of the behavioral problems associated
with ADHD; increased levels of stress are common as are
depression and marital discord (3,4). 
ADHD has been extensively studied in the USA over the
past 40 years and this has led to our detailed understand-
ing of the behavioral characteristics of the condition as it is
now defined by the American Psychiatric Association
(APA)’s DSM. However, this predominance of American
research in this field and apparent differences in the preva-
lence of ADHD, or hyperkinesis, as defined by the World
Health Organization (WHO) ICD, has also led to the
impression that this is largely an American disorder and is
much less prevalent elsewhere. For example, as pointed
out by Taylor and Sandberg (5), data from studies in the
late 1970s give a 20-fold greater prevalence of childhood
hyperactivity in North America compared with England.
Taylor (5,6) addressed this issue in a comparison of fac-
tor analyses for seven different studies of children from the
USA (3), UK, Australia, New Zealand, and Canada. He
found that in all studies, descriptions of being restless and
distractable formed a coherent factor corresponding to
hyperactivity, which was distinct from antisocial behaviors
such as defiance and aggressiveness. When the scores on
this hyperactivity factor were compared from the different
studies, they were found to be similar across the seven
studies. Taylor thus suggested that the prevalence of such
hyperactive behavior is probably similar across these dif-
ferent countries and that the apparent 20-fold difference
in the prevalence of hyperactivity reflects differences in
the definition of the condition rather than real differences
in behavior between British and American children. For
example, children with hyperactive behavior may be more
likely to be diagnosed as having conduct disorder in the
UK and ADHD in the USA.
This lack of a true difference in behavior between
American and British children was further confirmed in a
Scottish study of children referred to a Scottish Child
Guidance Service and a group of control children
(matched for age, sex, socio-economic status, and ability)
(7). All children were scored for hyperactivity using the
Conners’ 1969 Teacher Rating Scale, as used in the USA.
4.5% of the controls were scored as hyperactive. This fig-
ure is similar to the prevalence of hyperactivity in the USA
of 3-5% from studies using a similar definition (e.g. 8,9).
Of the referred children, 42.7% were scored as hyperac-
tive; this is comparable to the percentage (30-40%) of chil-
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dren referred to child guidance clinics in the USA who are
diagnosed as hyperactive (10). These data thus also sug-
gest that apparent differences in the prevalence of ADHD
reflect differences in diagnostic practice rather than true
differences in behavior.
However, the question still remains, whether ADHD is
largely an American disorder, perhaps stemming from
social and cultural factors which are more common in
American society. Alternatively, is this behavioral disorder
common to children worldwide, or to a large number of
races and societies, but not recognized by the medical
community, perhaps due to confusion regarding its diag-
nosis and/or misconceptions regarding its adverse impact
on children and their families and society as a whole, or
persistent concerns regarding its treatment with stimulant
drugs? This article reviews the available data regarding the
prevalence of ADHD in different countries and cultures
with a view to answering this question. 
Before presenting these data, it is necessary to consider
the factors which affect the prevalence figures arrived at in
such epidemiological studies. The most obvious of these
are probably the diagnostic criteria for ADHD, which
have been evolving over the last 20-30 years since the
terms ‘attention deficit’ and ‘hyperactivity’ were intro-
duced. Terms such as ‘minimal brain dysfunction’ and
‘organic brain dysfunction’ have also been used to
describe this behavioral disorder but have now largely
been superseded. The terms ‘hyperkinetic disorder’
(HKD) and ‘deficits in attention, motor control and per-
ception’ (DAMP) are still in use in the UK and a few other
European countries (HKD) and Scandinavia (DAMP).
(HKD defines a subset of patients with a particularly
severe form of ADHD.) Other factors which affect preva-
lence rates include characteristics of the sample popula-
tion, methods of diagnosis, and how rigorously diagnostic
criteria are applied. Each of these factors will now be con-
sidered in detail.
Over the years, the diagnostic criteria for the condition
now known as ADHD have evolved as research has fur-
thered our understanding of the distinctive characteristics
of the disorder. These developments can be mapped in the
series of definitions published by the APA in the updates
to their DSM and by the WHO revisions of the ICD.
‘Attention deficit disorder with hyperactivity’ (ADD-H)
was introduced as a defined disorder in the DSM-III in
1980 (11) and this was updated in 1987 with the revised
edition (DSM-III-R) (12), in which the disorder was rede-
fined as ‘attention deficit hyperactivity disorder’ (ADHD).
The disorder was redefined again in 1994 in the fourth edi-
tion of the DSM (DSM-IV) (1) and named ‘attention-
deficit/hyperactivity disorder’. The WHO definitions of
hyperkinesis have also been revised from the ICD-9 defi-
nition published in 1978 to their more recent definition in
ICD-10 published in 1992. While the WHO ICD-10 defi-
nition is still used in some countries, mainly in Europe,
there is now a general move to using the DSM-IV defini-
tion of ADHD, which should make comparison of data
between studies much easier.
This move towards a consensus for the definition of
ADHD should facilitate the development of a clear picture
of the worldwide epidemiology of the condition. Howev-
er, it is still complicated by differences in how rigorously
all the elements of the DSM-IV definition are applied. For
example, some researchers omit the requirement for symp-
toms to be present in at least two settings (e.g. 13), while
others omit the requirement for functional impairment
resulting from the symptoms (e.g. 14,15). Other factors
which affect the diagnosis of ADHD in different studies
are: the informants used to assess symptoms, e.g. whether
parents and/or teachers and/or subjects; and whether the
diagnosis is based on scores on behavior checklists (e.g.
16-18), or from direct interviews (e.g. 15) or both (e.g.
19,20).
Further variations in the apparent prevalence rate arise
from differences in the population surveyed. Epidemiolog-
ical studies of ADHD generally either use representative
community samples or school samples. An analysis of epi-
demiological studies in the USA found that community
samples gave higher prevalence rates than school samples
(mean prevalence: 10.3% for community samples vs. 6.9%
for school samples) (21). It is generally agreed that the
prevalence of ADHD is significantly greater in boys than
girls, especially in children. Thus the ratio of
males:females in the sample population can affect the
apparent prevalence and may need to be taken into
account. Similarly, the prevalence of ADHD is known to
vary with age. For example, three studies have shown
decreases in prevalence with increasing age over the age
range 10-20 years (22), 8-15 years (23), and 6-14 years
(24). Thus, even within studies of children, the age range
of the sample is likely to affect the apparent prevalence.
These confounding factors make it difficult to compare
the prevalence data for ADHD from one study and from
one country to another. It is necessary to take these factors
into account when comparing data from different studies.
METHODS
A MEDLINE search for the terms ADHD, ADD, HKD
or attention-deficit/hyperactivity disorder and prevalence,
combined with screening the reference lists of the
obtained studies, identified papers reporting on the preva-
lence of ADHD. Papers were then checked to ascertain
the population studied and the diagnostic criteria used.
Only studies sampling from the general population or a
well specified non-referred population (e.g., schools) were
included in the next stage. This eliminated three studies
that reported the prevalence of ADHD in clinic samples.
The remaining papers were analyzed according to the
diagnostic criteria employed. 
In 50 papers, diagnoses of ADHD or ADD-H were
based on DSM-III, DSM-III-R or DSM-IV criteria and
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these were included in the further analysis. (Two papers
employed DSM-III criteria but only presented data for
ADD without hyperactivity and were thus excluded.) Of
these 50 papers, 20 were studies of US populations and 30
were of non-US populations. A further four papers used
ICD-9 or ICD-10 diagnostic criteria (one study each from
the following countries: Hong Kong, Germany, France,
and India), and another five used other definitions of
hyperactivity (one study from each of the following coun-
tries: USA, UK, Sweden, Canada, and China). These nine
papers were not included in the more detailed analysis.
However, the populations studied in these papers were all
represented in the 50 papers which were included in the
further analysis, with the exception of France. Of note, no
studies of ADHD in African populations were identified
(except one unpublished study of children in Johannes-
burg described in Yao et al [25]), nor were there any stud-
ies in Eastern Europe. The selected studies cover a period
from 1982 to 2001. 
RESULTS
DSM-III studies
Thirteen studies were identified which included an
assessment of the prevalence of DSM-III ADD-H in chil-
dren and adolescents. These studies spanned the period
from 1982 to 1998 and included four studies of US popu-
lations and nine studies of non-US children. Two of the
more recent studies (16,26) also included assessments
employing the more recent DSM-III-R and DSM-IV diag-
nostic criteria and are thus valuable for determining the
effect of the diagnostic criteria on apparent prevalence, as
will be discussed later.
All four studies of US populations (Table 1) involved
children with a mean age of 9-11 years and investigated
children within a similar age range. The prevalence rates
for three of the studies lie within the range 9.1-12%. The
one study involving less than 100 children reported a
higher prevalence (18%) when teacher reports were used
to determine the diagnosis, but gave a lower value (8%)
when parent ratings were used (26). Of note, the study of
King and Young (27) only involved boys; the prevalence
rate of 12% at the upper end of the range for these studies
is consistent with the accepted observation that ADD-
H/ADHD is more prevalent in males than females.
Shekim et al (28) reported the prevalence of ADD-H, as
determined from interviews with subjects, interviews with
parents, and the rate of agreement between the two meth-
ods. When the assessment was based on the subject’s
reports of symptoms, a prevalence rate of 4% was report-
ed, and when the diagnosis was dependent on both parent
and subject reporting, this yielded a prevalence of only
2%. This suggests that children of this age are poor
informants of ADD-H/ADHD symptoms and agreement
between parents and subjects is poor, as is well recognized
(20,29,30).
Of the nine studies in non-US populations, two were in
adolescents (aged 15 years) (31,32) and reported preva-
lence rates of less than 1%. The remaining seven studies
(Table 2) involved children aged 4-16 years and with mean
ages of 7-11 years, and thus constitute a homogeneous age
range comparable to that of the US studies. These studies
reported prevalence rates in the range of 5.8-11.2%,
except for the study of Taylor et al (33), which involved
only boys and reported a higher prevalence of 16.6%, as
might be expected for a totally male sample. The study of
Leung et al (34) also involved a totally male population;
thus the 6.1% prevalence of hyperactivity in this study
may indicate a lower overall prevalence in Hong Kong
compared to other countries. The authors suggested that
both biological and cultural differences may account for
the prevalence rates of hyperactivity in Chinese children.
Interestingly, Taylor and Sandberg’s study (5) also report-
ed on the prevalence of hyperkinesis for their population
of school boys aged 6-8 years. This value, 1.7%, is approx-
imately one-tenth that of the reported prevalence of ADD-
H in the same study. This difference in prevalence between
hyperkinesis and ADD-H further supports Taylor’s sug-
gestion than the apparent difference in prevalence of
ADHD/hyperactivity between US and British children
stems from the difference in definition of the disorder
rather than true behavioral differences between the two
countries.
Table 1 Studies assessing prevalence of ADHD symptoms as defined by DSM-III in US children and adolescents
Author(s) Sample Assessment Informant Age Age Males in Sample Prevalence
method mean range sample size (%)
(years) (years) (%)
Bauermeister Children Interview Parent, 11 6–16 Not specified 614 9.1
et al (57) aged 4–16 (parent subject) teacher, subject
in Puerto Rico Report (teacher)
King et al (27) School Rating scale Teacher, subject 9.1 7–11 100 219 12
Newcorn et al (26) School Rating scale Parent, teacher 9.5 – 44 72 18 (teacher)
8 (parent)
Shekim et al (28) School Interview Parent, subject 9 – Not specified 114 12 (parent)
4 (subject)
2 (parent and subject)
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DSM-III-R studies
A total of 22 studies were identified which had
assessed the prevalence of ADHD using DSM-III-R crite-
ria. These included 10 studies of US populations and 12
studies of non-US populations and were performed over
a 12-year period from 1989 to 2001. As with the DSM-III
studies, several have also included diagnosis using DSM-
III or DSM-IV criteria and hence allow an estimation of
the impact of diagnostic criteria on the apparent preva-
lence of ADHD/ADD-H.
The details of the 10 US studies are given in Table 3,
with the exception of one study, which assessed preva-
lence in late adolescence and in young adults (age 16-22
years) (35). Five of the remaining studies involved chil-
dren aged 5-14 years and with a mean age between 8 and
10 years (17,26,36-38). A sixth study (22) presented
prevalence data for subjects aged 10-20 years, but report-
ed prevalence figures for three age ranges within the pop-
ulation; the lowest age range (10-13 years) fell within that
of the other five studies and thus was included in the
analysis. Data from these six studies gave prevalence rates
in the range 7.1-12.8%, with the outlier values of 26%
based on teacher assessments in the Newcorn et al study
(26), and 2.8% in the study of August et al (37). The New-
corn et al study involved less than 100 subjects from an
inner city school and thus may not be representative of
the general population. Also, the prevalence rate based
on parent assessments (11%) in this study does fall with-
in the range for the other studies. The study of August et
al (37) used an initial screen for disruptive behaviors that
employed a rather conservative threshold, so as to mini-
mize false positive identifications, followed by more
detailed screening to diagnose the particular disorders.
This use of a conservative initial screening method may
have led to an underestimation of prevalence. 
A seventh study (39) involved a slightly older popula-
tion than the other studies (aged 9-17 years, mean age 13
years) and reported a somewhat lower prevalence rate of
4.5% (based on parent reports). This is in keeping with
other data (e.g. 22) which indicate a decrease in preva-
lence with increasing age into adolescence and adult-
hood. Simonoff et al (40) also reported a low prevalence
rate (2.4%) for an older population (aged 8-16 years); this
was a population of Caucasian twin pairs and thus may
not be representative of the general population. Finally,
Lewinsohn et al (41) studied an adolescent population
and reported a particularly low prevalence rate of 0.41%.
However, this value was based on subject self reports of
symptoms, and adolescents are known to be poor
reporters of their own symptoms (42). 
Twelve studies of non-US populations were identified
which employed DSM-III-R diagnostic criteria. For one
of these studies (43) the same data were reported in terms
of DSM-IV criteria in a separate paper (44). The earlier
paper was therefore excluded from this analysis and the
later paper was reviewed with the other papers using
DSM-IV criteria. The remaining 11 studies are summa-
rized in Table 4. Four of these studies (23,45-47) involved
adolescents (for Gomez-Beneyto et al [23] a 15-year age
group) and report low prevalence rates (1.8-3.9%) as
would be expected for this older population. The remain-
ing eight studies (including the two younger age groups
included in study of Gomez-Beneyto et al [23]) involved
children aged 5-15 years and with a mean age of 6.5-11
Table 2  Studies assessing prevalence of ADHD symptoms as defined by DSM-III in non-US children and adolescents
Country Author(s) Sample Assessment Informant Age Age Males in sample Sample Prevalence
method mean range (%) size (%)
(years) (years)
Canada Szatmari Representative sample Rating scale Teacher, 10 4–16 50 2722 5.8
et al (58) of all children born (parent, parent, subject
between 1966 and teacher, subject*)
1979 living in Ontario
China Shen School Rating scale Teacher, subject 10.1 7–14 Not specified 2770 5.8
et al (59) (teacher)
Interview (subject)
Germany Baumgaertel School Rating scale Teacher 8.5 5–12 Not specified 1077 6.4
et al (16)
Hong Kong Leung  School Rating scale Teacher, parent – 7–8 100 3069 6.1
et al (34) (teacher) 
Interview
(parent, teacher)
India Bhatia Hospital Rating scale Teacher, subject 7.5 3–12 61 1000 11.2
et al (60) outpatient clinic (parent) (3–4 years: 
Interview 5.2
(parent, subject) 11–12 years: 
29.2)
The Verhulst Representative sample Rating scale Teacher, – 8 & 11 50 116 9.5
Netherlands et al (61) of children aged 8 or 11 (teacher, parent) parent, subject
years living Interview (subject)
in The Netherlands
UK Taylor School Rating scale Teacher, parent 7 6–8 100 3215 16.6
et al (33)
* Rating scale only administered to subjects aged 12–16 years.
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Table 3 Studies assessing prevalence of ADHD symptoms as defined by DSM-III-R in US children and adolescents
Author(s) Sample Assessment Informant Age Age Males in Sample Prevalence
method mean range sample size (%)
(years) (years) (%)
August and School Rating scale Teacher 9.79 5.33–14.25 Not specified 1038 8.6
Garfinkel (36)
August et al (37) School Interview Subject, 8 6–10 Not specified 7231 2.8
(subject) teacher, parent
Rating scale
(subject, teacher,
parent)
Cohen et al (22) Children originally Interview Parent, subject 11.5 10–13 52 541 12.8
sampled in 1975 when 15 14–16 48 508 8.9
aged 1–10 years and 18.5 17–20 50 446 6.0
living in an upstate 
New York county, 
plus sample of children
aged 9–12  living in urban
low income areas of the
original county in 1983
Lewinsohn School Interview Subject - 16–20 Not specified 1710 0.41
et al (41) (grade 9–12)
Newcorn School Rating scale Parent, teacher 9.5 – 44 72 26 (teacher)
et al (26) 11 (parent)
Pelham School Rating scale Teacher 9.5 5–14 100 931 7.1
et al (38)
Simonoff Population white twins Interview Subject, - 8–16 46.3 2762 pairs 2.4
et al (40) (subject, parent) parent, teacher
Rating scale (subject,
parent, teacher)
Shaffer et al (39) Sample of children aged Interview Parent, subject 13 9–17 Not specified 1285 4.5 (parent)
9–17 (details not given) 2.2 (subject)
Wolraich et al (17) School Rating scale Teacher 8 4–12 Not specified 8258 7.3
Table 4  Studies assessing prevalence of ADHD symptoms as defined by DSM-III-R in non-US children and adolescents
Country Author(s) Sample Assessment Informant Age Age Males in sample Sample Prevalence
method mean range (%) size (%)
(years) (years)
Canada Breton Representative sample Interview Parent, teacher, 10 6–14 Not specified 2400 8.9 (teacher)
et al (24) of children aged 6–14 subject 5.0 (parent)
years from throughout (6–11 years) 3.3 (subject)
Quebec
Finland Puura Representative sample Rating scale, Parent, subject 8.5 8–9 50 3397 6.6 (parent)
et al (62) of children born 1981–9 Interview 0.6 (subject)
and living in three areas 
in Southern Finland
Germany Baumgaertel School Rating scale Teacher 8.5 5–12 Not specified 1077 10.9
et al (16)
Israel Zohar Consecutive inductees Interview Subject – 16-17 67 562 3.9
et al (45) into the Israeli army
Italy Gallucci School Rating scale Teacher 9 8–10 50 232 3.9
et al (63)
Japan Kanbayashi School Rating scale Parent 8 4–12 48 1022 7.7
et al (64)
The Verhulst Representative national Interview Teacher, parent, 15.5 13–18 Not specified 780 1.8 (parent)
Netherlands et al (46) sample of children (parent, subject) subject 1.3 (subject)
aged 13–18 years Rating scale
(parent, subject,
teacher)
New Fergusson Birth cohort of children Interview Parent, subject 15 – Not specified 986 3.0 (parent) 
Zealand et al (47) born in Christchurch urban 2.8 (subject)
region in 1977
Spain Gomez- Representative sample of Interview Parent, teacher – 8 50 326 14.4
Beneyto children in Valencia of the 11 49 385 5.3
et al (23) defined ages 15 51 416 3.0
Sweden Landgren Children born in 1986–7 Rating scale Teacher, parent 6.5 6–7 Not specified 589 4.0
et al (65) and living in Mariestad, (parent, teacher)
a rural area of southern Interview (parent)
Sweden when aged 6 years
Taiwan Wang School Rating scale Teacher 9.5 7–12 52 4290 9.9
et al (66)
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years, comparable to that of the six US studies analyzed.
Prevalence rates for these eight studies ranged between
3.9% and 14.4%. 
DSM-IV studies
A total of 19 studies have now been published which
used the DSM-IV diagnostic criteria; this included eight
studies of US populations and 11 from non-US popula-
tions. Two of these studies also present prevalence data
according to DSM-III-R criteria (16,17) and DSM-III cri-
teria (16).
Of the eight US studies, one was in adults (48) and one
used more lenient criteria in order to select sufficient girls
for further study (49) and hence will not be discussed fur-
ther. Six studies reported the prevalence of ADHD symp-
toms (i.e. fulfilment of criteria A only) and gave rates of
9.5-16.1% (Table 5). When only the four studies of chil-
dren with mean ages of approximately 8-10 years are con-
sidered, this gives a prevalence range of 11.4-16.1%. Most
of these studies diagnosed ADHD on the basis of either
teacher or parent reports; only Rowland et al (50)
employed teacher and parent reports of symptoms.
Importantly, the data reported by Rowland et al are with-
in the range reported for studies using a single informant
and thus suggest that data from single-informant studies
may be valid for comparing prevalence rates. Wolraich et
al (18) reported the prevalence of ADHD both according
to symptoms alone (16.1%) and when functional impair-
ment was also required (6.8%). This indicates that esti-
mates of ADHD prevalence based on symptom assess-
ment alone are likely to be overestimates. However, such
data may be useful to assess the relative prevalence of
ADHD symptoms in different countries and cultures with
the caveat that this should not be equated with the actu-
al prevalence of ADHD. 
Of the 11 studies of non-US populations, all except
one (51) used teacher and/or parent assessments of
ADHD symptoms. Of these 10 studies, nine were in chil-
dren with a mean age between 7 and 11 years. These nine
studies reported rates of ADHD symptoms ranging from
2.4 to 19.8% (Table 6). Of these studies, five reported
rates in the narrower range of 16.0-19.8%, which is at the
high end of the range reported for the six US studies
which spanned a similar age range. The studies that
reported lower rates (2.4-7.5%) were the two studies of
Australian populations, the only study of an Icelandic
population, and the Swedish study. The low rates in the
Australian, Icelandic and Swedish studies may reflect cul-
tural differences in these populations. However, it is
interesting to note that in one of the Australian studies
(52), which reported the lowest prevalence rate (2.4%)
when using combined teacher and parent assessments,
the prevalence rates based on parent assessments alone
(9.9%) and teacher assessments alone (8.8%) were simi-
lar to those reported in the US studies. Two studies addi-
tionally reported prevalence rates based on functional
impairment and these rates were lower than those for
symptoms alone - symptom prevalence, 7.5%; impair-
ment prevalence, 6.8% (19); symptom prevalence, 15.8%;
impairment prevalence, 0.2% (53) - in agreement with the
findings of Wolraich et al (18).
Comparison of prevalence rates 
Table 7 shows the range of prevalence rates for US and
non-US populations for the three DSM diagnostic crite-
ria when outlying values have been excluded. Compari-
son of the prevalence range for the US studies shows that
the highest prevalence is reported when using DSM-IV
criteria, as has previously been shown by Wolraich et al
(17) and Baumgaertel et al (16). The non-US studies also
showed a higher prevalence of ADHD when using DSM-
IV diagnoses. As Table 7 shows, the range of prevalence
Table 5 Studies assessing prevalence of ADHD symptoms as defined by DSM-IV in US children and adolescents
Author(s) Sample Assessment Informant Age Age Males in Sample Prevalence
method mean range sample size (%)
(years) (years) (%)
Gimpel Sample of children Rating scale Parent 4 2–6 54 253 9.5
and Kuhn (67) enrolled in daycare 
centers in Utah 
and Nebraska
Hudziak Female twins Interview Parent - 13.5-19.5 0 1269 pairs 9.9
et al (68) in community
Nolan School Rating scale Teacher 10.5 3–18 54 3006 15.8
et al (69)
Rowland School Rating scale Teacher and parent - 8–12 Not specified 362 16
et al (50) (teacher)
Interview (parent)
Wolraich School Rating scale Teacher 8 4–12 Not specified 8258 11.4
et al (17)
Wolraich School Rating scale Teacher - 4–12 Not specified 4323 16.1 (symptoms)
et al (18) 6.8
(functional impairment)
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reported in the non-US studies is, for each diagnostic
system, similar to that reported in the US studies.
Several of the non-US DSM-III-R and DSM-IV stud-
ies found fairly low prevalence figures, between 2.4 and
7.5%. The countries included in the low-prevalence
group are Sweden (2/2 studies in this population), Italy
(1/1 study in this population), Australia (2/2 studies in
this population), Iceland (1/1 study in this population),
and Spain (1/1 study, but only for 11 years age group).
This may reflect a true lower prevalence in these coun-
tries but further studies are required to confirm this.
These countries are not represented in the studies using
DSM-III diagnostic criteria.
DISCUSSION
The results of studies using DSM criteria suggest that the
prevalence of ADHD/ADD-H is at least as high in many
non-US children as in US children. Certain populations
may have a lower prevalence of ADHD symptoms (e.g.,
Iceland, Australia, Italy, and Sweden), but this cannot be
concluded on the basis of the available data. Direct com-
parisons between different populations are required to
truly assess the relative prevalence of ADHD symptoms in
different cultures and countries. To date, only one such
study has been performed. Gadow et al (15) reported on
the prevalence of ADHD symptoms in a sample of 600
Ukrainian children (aged 10-12) and an age-matched sam-
Table 6  Studies assessing prevalence of ADHD symptoms as defined by DSM-IV in non-US children and adolescents
Country Author(s) Sample Assessment Informant Age Age Males in sample Sample Prevalence
method mean range (%) size (%)
(years) (years)
Australia Gomez School Rating scale Parent, teacher 8 5–11 47.4 1275 2.4 (parent/teacher)
et al (52) 9.9 (parent)
8.8 (teacher)
Graetz Representative national Interview and Parents 6–17 Not specified 3597 7.5
et al (19) sample of children rating scale (symptoms)
aged 6–17 years 6.8
(functional 
impairment)
Brazil Guardiola School Interview Investigator 7.5 7–8.8 49.4 484 18
et al (70)
Rohde School Rating scale Subject 13 - 49 1022 5.8
et al (71)
Colombia Pineda School Rating scale Parent 9.1 4–17 50 540 16
et al (14)
Pineda School Rating scale Parent, teacher 10.5 4–17 54 341 17.1
et al (72)
Germany Baumgaertel School Rating scale Teacher 8.5 5–12 Not specified 1077 17.8
et al (16)
Essau  Community Rating scale Parent, subject 14.5 12–17 41 1009 15.8 (symptoms)
et al (53) and interview 0.2 (functional 
impairment)
Iceland Magnusson School Rating scales Parent, teacher 7 6–8 47 429 5.7 (teacher) 
et al (13) 4.7 (parent)
Sweden Kadesjo School Interview Parent, teacher 7 6.5–7.5 Not specified 409 3.7
and Gillberg (44) (teacher, parent)
Rating scale (teacher)
Ukraine Gadow Sample of former Interview Parent, teacher 10.8 10–12 48.3 600 19.8
(and USA) et al (15) refugees from Chernobyl (Ukraine) (Ukraine) (Ukraine) (Ukraine) (Ukraine)
living in Kyiv in 1996 10.9 9–12.9 51.4 (USA) 443 (USA) 9.7 (USA)
(USA) (USA)
Table 7 Prevalence ranges for ADHD/ADD-H according to DSM diagnostic criteria for US and non-US populations
N Approximate range for mean age (years) Prevalence range
DSM-III
US studies 4 9–11 9.1–12 (n = 3)
non-US studies 7 7–11 5.8 –11.2 (n = 6)
DSM-III-R
US studies 6 8–12 7.1–12.8 (n = 4)
non-US studies 9 6–11 3.9–10.9 (n = 7) 
DSM-IV
US studies 4 8–10 11.4–16.1 (n = 4)
non-US studies 9 7.5–11 16–19.8 (n = 5) (higher prevalence studies)
2.4–7.5 (n = 4) (lower prevalence studies)
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ple of 443 US children. The Ukrainian children were a
sample of those living within 30 km of the Chernobyl
nuclear power plant who were evacuated to Kyiv and
remained living there 10 years later. This study reported a
prevalence of ADHD symptoms of 19.8% for Ukrainian
children compared with 9.7% for the US sample. It is
unclear why the prevalence of ADHD symptoms should
be so much higher in the sample of Ukrainian children. It
is possible that the higher Ukrainian prevalence reflects
the environmental adversity and psychosocial dislocation
associated with the Chernobyl disaster, but we can draw
no firm conclusions in the absence of an appropriate
Ukrainian control group.
While the populations studied in the papers included in
this report are not necessarily representative of all child
populations worldwide, they are sufficient to demonstrate
that ADHD is not purely an American disorder and that
the prevalence of this behavioral disorder in many coun-
tries is in the same range as that in the USA. Although a
number of prevalence studies were not included in this
analysis because they employed other diagnostic criteria,
such as the ICD-9 and ICD-10 criteria, the populations
they studied are for the most part represented in the selec-
tion of studies included in this analysis. Thus, the decision
to include only studies employing DSM diagnostic criteria
was unlikely to make the selected studies unrepresentative
of the populations studied to date. 
Recognition of ADHD as a disorder affecting a signifi-
cant percentage of children in many countries has impor-
tant implications for the psychiatric care of children.
Numerous studies have shown that appropriate manage-
ment can significantly impact on the symptoms of ADHD
and thus help children and their families overcome and
live with the burden of this disorder (54,55). Management
options include: educational strategies which help the
child and adolescent achieve their academic potential at
school and college; behavioral treatments aimed at teach-
ing the child, their parents and teachers how to modify
problem behaviors; and pharmacotherapy which has been
shown to be highly effective for the long-term control of
core symptoms. However, in the absence of adequate
recognition of the disorder by the medical community, the
teaching profession and the public in general, children
with this behavioral disorder are unlikely to receive the
assistance they require to achieve their full potential, at
school, at home, and into adulthood.
In conclusion, the data from studies using DSM criteria
to assess the prevalence of ADHD in representative child
and adolescent populations suggest that there is no con-
vincing difference between the prevalence of this disorder
in the USA and most other countries or cultures. It is dif-
ficult to make exact comparisons between countries
because the estimated prevalence is highly influenced by
the means of assessment and the type of sample recruited.
However, the range of prevalence rates for DSM symp-
toms reported in US child populations appears to fall
within those reported for non-US child populations
(except for those of Iceland, Australia, Italy and Sweden). 
One limitation of the literature we reviewed is the
reliance of many studies on rating scale measures rather
than interviews with patients and parents. Unlike rating
scale methods, interview-based procedures come close to
reproducing the results one might expect from a clinical
evaluation and are better able to incorporate the impair-
ment and pervasiveness criteria of the DSM diagnoses of
ADHD. Further interview-based studies assessing the
prevalence of ADHD as defined by the DSM-IV criteria,
and directly comparing the prevalence in different coun-
tries, are required to provide a clearer picture of the bur-
den of ADHD worldwide. We have also relied on the
DSM as a method of comparing the cross-cultural preva-
lence of ADHD. As discussed by Hartman et al (56), it is
possible that improved operationalization of symptoms
could lead to increased measurement precision and a bet-
ter assessment of the cross-national validity of diagnostic
categories. In addition, this research needs to be followed
up into clinical practice, with a better awareness of this
disorder and the effective means of alleviating the associ-
ated symptoms and its burden on the individual and soci-
ety as a whole.
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